By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Files Patent Application To Treat Cytokine Release Syndrome, A Potentially Life-Threatening Complication Of CAR-T Cell Therapy 9/18/2017 7:47:16 AM
Can-Fite BioPharma (CFBI) Reports Second Quarter 2017 Financial Results & Provides Clinical Update 9/1/2017 6:41:27 AM
Can-Fite BioPharma (CFBI) Receives Milestone Payment From CKD Pharmaceuticals Its Distribution Partner In Korea 8/23/2017 7:26:38 AM
Can-Fite BioPharma (CFBI) Completes Patient Enrolment For Its Phase II Study Of Namodenoson In The Treatment Of Liver Cancer 8/9/2017 6:35:50 AM
Can-Fite BioPharma (CFBI) Successfully Completes Human Cardiodynamic Safety Trial For Piclidenoson 8/7/2017 6:25:51 AM
Can-Fite BioPharma (CFBI)’s Phase II NAFLD/NASH Trial With Namodenoson Set To Commence Patient Enrollment Following Conclusion Of Successful Clinical Investigator Meeting 7/17/2017 6:09:50 AM
Can-Fite BioPharma (CFBI) Concludes Successful Clinical Investigator Meeting For Its Acrobat Phase III Trial Of Piclidenoson In The Treatment Of Rheumatoid Arthritis 6/8/2017 6:25:53 AM
Can-Fite BioPharma (CFBI) Establishes Clinical Advisory Board For NAFLD/NASH 6/5/2017 10:26:30 AM
New Preclinical Data On Can-Fite BioPharma (CFBI)'s Namodenoson To Be Presented At 1st International Conference On Fatty Liver In Seville, Spain On June 2, 2017 6/1/2017 8:05:50 AM
Can-Fite BioPharma (CFBI) Reports First Quarter 2017 Financial Results & Provides Clinical Update 5/30/2017 8:32:23 AM